Background/Aims: Increasing wall stress or biomechanical stretch experienced by arteries influences the initiation of atherosclerotic lesions. This initiation is mediated by Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ), which are both effectors of the Hippo pathway. In this study, the functional roles of YAP/TAZ proteins in the regulation of the stretch-mediated programing of human umbilical arterial smooth muscle cells (HUASMCs) to a proliferative phenotype were examined. Methods: HUASMCs were seeded on a Matrigel-coated silicone chamber and subjected to biomechanical stretch for 24 h after 48 h of growth. YAP/TAZ small interfering RNA was used to specifically knockdown YAP/ TAZ expression in HUASMCs. Results: We observed that YAP/TAZ activation via biomechanical stretching is involved in the regulation of critical aspects of the HUASMC phenotypic switch. YAP/TAZ knockdown significantly attenuated the stretch-induced proliferative and proinflammatory phenotypes in HUASMCs. Furthermore, treatment with atorvastatin, an antiatherosclerotic drug, attenuated the stretch-induced phenotypic switch of HUASMCs from the contractile to synthetic state by suppressing YAP/TAZ expression. Additional investigations demonstrated the role of stretch in inhibiting the Hippo pathway, leading to the activation of PI3-kinase (PI3K) and phosphoinositide dependent kinase (PDK1); the key molecule for the regulation of the PDK1 and Hippo complex interaction was Sav1. These results showed
Introduction
Vascular smooth muscle cells (VSMCs) are essential for maintaining vessel homeostasis. These cells are capable of proliferating and expressing different phenotypes when exposed to alterations in environmental and hormonal stimuli, such as changes in cytokine stimulation, cell adhesion, injuries to vessels, and increased mechanical force [1] . Changes in biomechanical force are especially important with respect to vascular biology; they affect the arterial and venal cells under both physiological and pathophysiological conditions. Despite multiple studies demonstrating associations between specific biomechanical force alterations with vascular remodeling, the mechanisms underlying these associations are still unclear [2] [3] [4] .
Shear stress and cyclic strain are the two primary mechanical forces normally experienced by large arteries [5] . The endothelium experiences shear stress as blood flows through the lumen as well as cyclic strain; the latter is also experienced by VSMCs. It should be noted that cyclic strain is a major determinant of both normal VSMC physiology and pathophysiology, playing a crucial role in hypertension, vein-graft intimal hyperplasia and failure, restenosis, and atherosclerosis [6] . Indeed, growing evidence indicates that cyclic strain modulates VSMC functions in the media of the arterial wall [7] . The chronic elevation of strain levels, such as in hypertension, stimulates VSMCs to mediate vascular remodeling [8, 9] . This process requires VSMC proliferation, remodeling, and migration, which necessitates the ability to sense and adapt to mechanical stresses. Therefore, a key topic regarding the cyclic strain response is the molecular bases for the capacities of VMSCs to sense and adapt to stress as well as the resulting alterations in gene regulation and signaling via downstream effectors.
One of the signaling pathways involved in mediating the VMSC stretch response is the Hippo signaling pathway, an evolutionarily conserved pathway that inhibits cell proliferation. Indeed, other researchers have shown that a loss of Hippo signaling leads to organ overgrowth and cancer development [10] [11] [12] [13] . However, the activation of this pathway leads to the phosphorylation and subsequent cytoplasmic retention of the downstream effectors Yes-associated protein (YAP) and transcriptional co-activator with PDZ-binding motif (TAZ), thereby inhibiting their activity [14] . These effectors are mechanical stimuli sensors, especially with respect to matrix stiffness, stretch, and cell density [15] .
However, the exact role of YAP/TAZ in cell stretch-mediated vascular remodeling is unclear. The well-characterized YAP/TAZ target genes CTGF and CYR61 are highly expressed in human atherosclerotic lesions but not in normal human arteries [16] . Additionally, lysophosphatidic acid, a major atherogenic factor, is a potent YAP/TAZ activator [17] . Other biochemical factors, such as cytokines, growth factors, and drugs, are able to regulate YAP/ TAZ activity and the resulting functional outcomes [18] [19] [20] [21] . Moreover, YAP has been suggested to play a role in mediating vascular remodeling in carotid stenosis progression [22] . In fact, the strongest YAP inhibitors are the well-known anti-atherosclerotic drugs statins [20] .
Given the demonstration that YAP is a potent cell proliferation and migration factor, we hypothesized that YAP plays an important role in the phenotypic switching of VSMCs, which may result in vascular remodeling. The purposes of this research were to test the hypothesis that arterial wall stress and stretch, produced by intraluminal pressure, contribute to the VSMC phenotypic switch and to investigate the underlying mechanisms. 
Materials and Methods

Cell culture and treatment
Human umbilical arterial smooth muscle cells (HUASMCs) were purchased from the American Type Culture Collection (Manassas, VA), and were grown in accordance with the manufacturer's specifications. Cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum (FBS), 50 U/mL penicillin, and 50 μg/mL streptomycin and fungizone (Invitrogen, Carlsbad, CA). These cells were then seeded on a Matrigel-coated silicone chamber at a density of 2 × 10 4 cells/cm 2 . Biomechanical stretch was applied using a Flexcell FX-5000 tension system at a frequency of 0.5 Hz, with elongation from 0% to 13%, for 24 h after 48 h of growth. Cells were also exposed to the following reagents: 20 μM SP600125 (Calbiochem, San Diego, CA), 20 μM SB203580 (Sigma-Aldrich, St. Louis, MO), 10 μM U0126 (Cell Signaling, Danvers, MA), 4 μM LY294002 (Calbiochem), 20 μM AKT inhibitor II (Calbiochem), and 5 μM PDK1 inhibitor (Sigma-Aldrich).
Transfection with small interfering RNA For gene silencing by small interfering RNA (siRNA), a small double-stranded RNA is used to target mRNAs for degradation. The YAP/TAZ-siRNA duplexes were synthesized by Shanghai GenePharma Co., Ltd. (Shanghai, China) as follows: siRNA-YAP: 5′-UUCUUUAUCUAGCUUGGUGGC-3′; siRNA-TAZ: 5′-CAGCCAAAUCUCGUGAUGAAU-3′; siRNA-Mst1: 5′-GCUUGCAUGAGGACUACAGAU-3′; siRNA-SAV1: 5′-GCUUGCAUGAGGACUACAGAU-3′. Control group cells were treated with either transfection reagents (vehicle) or with non-targeting siRNA (siRNA-NC: 5′-UUCUCCGAACGUGUCACG-3′). Cells were transfected with 200 nM siRNA using the X-treme siRNA Transfection Reagent (Roche Applied Science, Penzberg, Germany) in accordance with the manufacturer's instructions.
Cell proliferation assay HUASMC proliferation was determined by 5-ethynyl-2-deoxyuridine (EdU) incorporation (RiboBio, Guangzhou, China). Cells were fixed and stained after incubation following the manufacturer's specifications. The proliferation rate was calculated after normalization of the number of EdU-positive cells to the number of total nuclei (DAPI-stained cells) in five random fields.
For the cell cycle analysis, cells were trypsinized after 48 h, washed twice with phosphate-buffered saline (PBS), and fixed in 75% ethanol overnight. After washing twice with PBS, the cells were incubated with RNase A (20 mg/mL) at 37°C for 30 min, followed by staining with propidium iodide (0.5 mg/mL) at 4°C for 30 min. Afterwards, cells were washed and resuspended in 500 μL of PBS, and the DNA content was detected using a Becton Dickinson flow cytometer (BD Diagnostics, Sparks, MD).
Reverse transcription quantitative PCR
Total RNA was isolated from HUASMCs using RNA Bee Reagent (Cosmo Bio Inc., Tokyo, Japan). The total RNA was then prepared for first-strand cDNA synthesis by using the QuantiTect Reverse Transcription Kit (Qiagen Inc., Hilden, Germany). Reverse transcription quantitative PCR (RT-qPCR) was then performed using Thermal Cycler Dice TP800 (Takara Bio Inc., Kusatsu, Japan) with SYBR Premix Ex Taq II (Takara Bio Inc.), according to the manufacturer's instructions. Each cDNA sample was run in triplicate. The data were averaged, and standard deviations (SDs) were calculated. GAPDH was used as a standard control, and Table 1 describes the primers used in this study.
Protein extraction
Nuclear protein extraction was performed as follows. HUASMCs were lysed using buffer I (10 mM HEPES, 10 M KCl, 1 M EDTA, 1 μM EGTA, 15% Nonidet, protease inhibitors, and phosphatase inhibitors) and then centrifuged (12000 × g, 4°C, 15 min). After centrifugation, the supernatant (cytosolic fraction) was collected. The remaining pellet, containing the nuclear fraction, was dissolved in 40 μL of buffer II (20 mM HEPES, 400 mM NaCl, 10 mM EDTA, 10 mM EGTA, 15% Nonidet, protease inhibitors, and phosphatase inhibitors). The resulting solution was then sonicated twice, each time for 5 s, at 50 W and 4°C. After centrifugation (12000 × g, 4°C, 15 min), the supernatant containing the nuclear fraction was collected and stored at -80°C.
Western blotting
Protein samples were loaded onto a sodium dodecyl sulfate polyacrylamide gel (4-15%) and run under standard conditions. The separated proteins were then transferred to polyvinylidene difluoride membranes (PVDF; Millipore, Billerica, MA). The membranes were blocked with 5% nonfat milk at room temperature for 1 h in Tris-buffered saline with Tween-20 (TBST). Membranes were then incubated with primary antibodies against YAP (1:1000); p-YAP (1:1, 000; Ser 127); TAZ (1:1000); ICAM-1 (1:1000; CD54); VCAM-1 (1:1000); NFκB-p50 (1:1000); α-smooth muscle actin (1:1000); smooth muscle myosin heavy chain (1:1000); calponin-1 (1:1000); Sav1 (1:1000); Lats1 (1:1000); PDK1 (1:1000); MST (1:1000) (all from Cell Signaling Technology); GAPDH (Abcam, Cambridge, UK), and histone (Abcam) overnight at 4°C. After 3 washes with TBST, these membranes were then incubated for 60 min with peroxidase-conjugated Affinipure goat anti-rabbit IgG (H+L) and anti-mouse IgG (H+L)-labeled secondary antibodies (both 1:2000). The membranes were washed in TBST with 0.5% Tween-20 before electrochemiluminescence (ECL) detection using BeyoECL Plus (Beyotime Institute of Biotechnology, Haimen, China). After ECL detection and exposure to X-ray film, the blots were stripped in 5 mL of stripping buffer (CoWin Biotech, Beijing, China) for 15 min at room temperature, followed by hybridization with an antibody against histones for normalization. Densitometric analysis of the resulting protein bands was conducted using the Tanon Gel Imaging System (Shanghai Tanon, Shanghai, China).
Cell migration assay
For the migration assay, the cells were resuspended at 1 × 10 6 cells/mL after 24 h of starvation; 200 μL of cell suspension (2 × 10 5 cells) was seeded into the upper chambers (24-well insert), while medium supplemented with 10% FBS was placed in the lower chamber. After 48 h of incubation, the cells on the top side of the inserts were removed gently with a cotton swab. The inserts were then fixed with 4% methanol for 15 min, followed by 0.1% crystal violet staining for 15 min. The average migratory cells were counted by randomly choosing five fields for observation under a microscope, and this was repeated at least three times. 1A) . Moreover, an RT-qPCR analysis revealed that the expression levels of YAP/ TAZ target genes, including CYR61, CTGF, and ANKRD1, increased significantly in response to biomechanical stretch (Fig.  1B) . This finding demonstrated that stretching could be involved in inducing the activation and nuclear localization of YAP/TAZ, and thus the activation of genes involved in HUASMCmediated vascular remodeling.
YAP/TAZ regulated HUASMC growth and cell cycle progression
To investigate whether biomechanical stretch affected HUASMC growth, EDU labeling, and flow cytometry experiments were performed using cells treated with siRNAs against YAP/TAZ. Those cells were compared with cells that were not treated with siRNAs (siRNA-NC, or negative control cells). After transfection, western blotting revealed that YAP/TAZsiRNA-transfected cells had lower YAP/TAZ protein levels than those in siRNA-NC treated cells ( Fig. 2A) . Furthermore, the proliferation results based on EDU labeling suggested that proliferation was lower in YAP/TAZ-siRNA-transfected cells (5.5 ± 1.2%) than in siRNA-NC cells (7.2 ± 1.3%). In addition, YAP/TAZ-siRNA cells subjected to biomechanical stretch exhibited lower (18.87 ± 4.63%) proliferation levels than those of the biomechanical stretch group without YAP/TAZ siRNA treatment (13.5 ± 2.3%) (Fig. 2B) .
Next, the DNA content was examined by flow cytometry, which showed that the biomechanical stretch group exhibited greater cell proliferation (25.31 ± 1.5%, S phase) than that in the non-stretched groups. By contrast, transfection of YAP/TAZ siRNA with or without biomechanical stretch decreased cell proliferation (7.32 ± 0.84% and 6.04 ± 0.3%, S phase, respectively) compared with that in the siRNA-NC-treated control group (11.14 ± 0.5%, S phase) (Fig. 2C) . To evaluate the regulation of YAP in cell cycle progression, the expression levels of Cyclin A1 and proliferating cell nuclear antigen (PCNA) during the G1-to-S transition were examined. Cyclin A1 and PCNA abundances were markedly increased in stretch-stimulated HUASMCs; these abundances decreased after treatment with YAP/ TAZ siRNAs (Fig. 2D) . These results suggested that biomechanical stretch was involved in programming HUASMCs toward a proliferative phenotype, and that YAP/TAZ played a role in proliferation, as decreased expression resulting from RNA interference led to reduced cell proliferation.
YAP/TAZ activation promoted the stretch-induced pro-inflammatory response
To investigate whether YAP/TAZ mediated the pro-inflammatory response in HUASMCs under biomechanical stretch, inflammatory cytokine gene expression was examined by RTqPCR. Tumor necrosis factor α expression was upregulated in stretch-induced HUASMCs and was decreased upon treatment with YAP/TAZ siRNAs (Fig. 3A) . Cytokine mRNA levels between the two groups were also evaluated. Based on RT-qPCR, the levels of interleukin (IL)-1β, IL-6, and IL-8 were significantly elevated in stretch-induced HUASMCs, and such increases were offset by YAP/TAZ siRNA treatment (Fig. 3B) . The relationship between biomechanical stretch and NF-κB activation was also evaluated by examining NF-κB p50 expression level, which was up-regulated in the stretched group and decreased following YAP/TAZ knockdown (Fig. 3C) . Additionally, since atherosclerosis is also involved monocyte attachment to HUASMCs, western blotting was used to examine the protein levels of the cell adhesion molecules VCAM-1 and ICAM-1. Biomechanical stretch up-regulated VCAM-1 and ICAM-1 levels in HUASMCs, while YAP/TAZ knockdown attenuated their expression, after likely induction by inflammatory cytokines (Fig. 3D) . Taken together, these results indicated that wall stress may induce HUASMC inflammation, which in turn contributed to vascular remodeling and atherogenesis. (Fig. 4A) .
With respect to the influence of biomechanical stretch on HUASMC migration, a Transwell plate was used to assay cell migration. Biomechanical stretch significantly increased HUASMC migration compared with that in the control group, and YAP/TAZ siRNA transfection or atorvastatin treatment abrogated stretch-induced HUASMC migration (Fig.  4B) . Taken together, these results indicated that statin attenuated the stretch-induced phenotypic switch of HUSMCs from a contractile to a synthetic state by suppressing YAP/ TAZ expression and activity.
Statins inhibited YAP/TAZ expression via PI3K and PDK1
Several reports have demonstrated that angioplasty results in arterial wall stretch, leading to rapid mitogen-activated protein kinase (MAPK) activation in regenerating carotids. The role of biomechanical stretch in YAP/TAZ pathway mediation was further investigated using various specific pharmacologic inhibitors of its downstream pathways, including U0126 (mitogen-activated protein kinase inhibitor), SB203580, (p38 MAPK inhibitor), LY294002 (PI3K inhibitor) AKT inhibitor II (AKT inhibitor), and phosphoinositide-dependent kinase (PDK1) inhibitor II (PDK1 inhibitor). Western blotting showed that YAP and TAZ nuclear abundances were markedly decreased in stretch-stimulated HUASMCs upon the inhibition of PI3-kinase activity with LY294002. Moreover, an inhibitor of the PI3K downstream effector, PDK1, was also able to block YAP nuclear accumulation (Fig. 5) . However, inhibiting AKT, another major kinase downstream of PI3K, had no effect on YAP nuclear accumulation. These results demonstrated that biomechanical stretch regulated YAP/TAZ activity in HUASMCs via the PI3K-PDK1 pathway.
Interaction between PDK1 and the Hippo complex was mediated by Sav1
The core components of the mammalian Hippo pathway include serine/threonine kinases Mst1/2 (Hippo/Hpo homologs), Lats1/2 (Warts/Wts homologs), and the adaptor proteins Sav1 (Salvador/Sav homolog) and Mob (Mats homologs). Some proteins of the 
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Hippo kinase cascade, including Mst, Sav1, and Lats, form a complex. To elucidate whether PDK1 was involved in the same complex as the Hippo pathway kinases, co-immunoprecipitation (co-IP) with endogenous PDK1 was used. Sav1, Mst, and Lats1 co-immunoprecipitated with endogenous PDK1. The interaction of PDK1 with these components was disrupted after 12 h of biomechanical stretch (Fig.  6A) . However, pretreatment with a PI3K inhibitor and PDK1 inhibitor blocked the effects of stretch-induced complex dissociation. These results suggested that stretch-induced complex dissociation depended on PI3K-PDK1 pathway activity and PDK1 was a component of the Hippo pathway complex.
To further confirm the association of PDK1 in the Hippo complex, siRNA and co-IP were used to examine the interaction between PDK1 and the Hippo complex. PDK1 activation triggered the dissociation of the Hippo core kinases from the scaffolding protein SAV1/WW45, leading to the inactivation of Lats, dephosphorylation, and YAP nuclear translocation. Thus, Sav1 may mediate the association between Lats and PDK1. Further analyses of the interaction between Mst and PDK1 showed that Mst silencing abrogated the Lats and PDK1 association. Moreover, the loss of Sav1 also abolished PDK-Lats and PDK1-Mst interactions ( Fig. 6B and C) . Thus, Sav1 was collectively shown to be the key molecule regulating the PDK1-Hippo complex interaction.
Discussion
Increases in wall stress and biomechanical stretch are a consequence of hypertension and are potent drivers of arterial remodeling. Our results indicated that YAP/TAZ expression in HUASMCs promotes cell proliferation and induces a phenotypic switch, and these effects are reversed upon silencing endogenous YAP/TAZ. Furthermore, we investigated whether YAP/TAZ is involved in mediating statin-modulated athero-protective effects. Our results proved that YAP/TAZ inactivation under statin treatment had inhibitory effects on cell proliferation and inflammation. Other studies have demonstrated that in stretch-stimulated VSMCs, various serine/threonine protein kinases, such as MAPK family proteins, are activated [7, 23, 24] . Indeed, our observation that YAP/TAZ activity is mediated by PI3K and PDK1 suggested that PI3K signaling activation inhibited the Hippo pathway. To further investigate the role of PDK1 in the Hippo complex, we examined the PDK1-Hippo interaction by co-IP. We discovered that the loss of Sav1 abolished PDK-Lats and PDK1-Mst interactions, suggesting that Sav1 is the key molecule regulating PDK1-Hippo interactions. YAP/TAZ, with a regulatory role in HUASMC inflammation and proliferation, may be involved in the induction of vascular remodeling.
In the vascular system, smooth muscle-specific YAP deletions lead to profound cardiac defects and vascular malformation [25] . The induction and activation of YAP expression following arterial injury deteriorates neointima formation and subsequent stenosis due to resulting VSMC proliferation [22] . We demonstrated that YAP/TAZ translocation results in significant changes in HUASMC growth, indicating its essential roles in proliferation and cell cycle progression. In addition, biomechanical stretch enhanced YAP/TAZ activation and induced a strong pro-inflammatory response in HUASMCs; YAP/TAZ silencing attenuated cell adhesion molecule and inflammatory cytokine expression. These findings indicated that YAP/TAZ activation may exert a proinflammatory effect on atherosclerotic lesions. LATS kinases canonically control YAP/TAZ activity via the regulation of YAP phosphorylation status and subsequent cytoplasmic/nuclear localization [26] . Moreover, mechanical stimuli adjust YAP/TAZ activity in a Rho-GTPases/actomyosin-dependent manner [27, 28] . Along with the Hippo and Rho pathways, other known mechano-sensors, such as G protein-coupled receptors, integrins [17, 29] , AMP-activated protein kinase, and VE-cadherin-mediated PI3K/ AKT signaling [30, 31] , regulate YAP/TAZ activity via phosphorylation. However, despite the crucial roles of PI3K and PDK1 in the growth factor regulation of Hippo signaling, AKT, a major effector kinase that acts downstream of these proteins, did not appear to be involved in Hippo pathway regulation in the present study. These findings suggested that alternative effectors may be present. It should be noted that even though PDK1 is known to act via other substrates, our results suggested that PDK1 directly controls the Hippo pathway [32] . However, the specific Hippo signaling pathway protein that is phosphorylated by PDK1 has not been clearly identified.
Conclusion
We demonstrated that YAP/TAZ serves as a critical mechano-transducer in the regulation of smooth muscle cell proliferation and inflammation. Therefore, the stretch-induced activation of YAP/TAZ may constitute a novel regulatory mechanism during stretch or wall stress-induced maladaptive remodeling processes in the early phases of atherosclerosis.
Cellular Physiology
and Biochemistry Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry
